HemaCare collects, processes and distributes human blood products to hospitals and research-related organizations. We operate donor centers and mobile donor vehicles to collect transfusable blood products from donors, and offer human-derived blood products to health research organizations. HemaCare also provides blood related services, principally therapeutic apheresis procedures, stem cell collection and other blood treatments, to patients and in connection with clinical trials.

Although most suppliers of transfusable blood products are organized as not-for-profit, tax-exempt organizations, all suppliers charge fees for blood products to cover their costs of operations. The Company believes that it is the only investor-owned and taxable organization operating as a transfusable blood supplier with significant operations in the U.S. The research specimen industry includes many suppliers from small limited service providers to large fully integrated service organizations.

Full News Links

HemaCare Reports Profitable Second Quarter

LOS ANGELES, CA--(MARKET WIRE)--Aug 13, 2008 -- HemaCare Corporation announced today a substantial improvement in the second quarter of 2008 when compared to the same period of 2007. Net income in the quarter was $428,000. In the second quarter of 2007, the Company reported a loss of $413,000. Sales from continuing operations were $9.6 million, 14% greater than the same period of 2007. Net income from continuing operations was $165,000, compared to a second quarter 2007 loss of $614,000.

Value per share is around .40